Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov:268:110364.
doi: 10.1016/j.clim.2024.110364. Epub 2024 Sep 13.

High symptom burden in female X-linked chronic granulomatous disease carriers

Mary Ann Miranda  1 , Athanasios Tsalatsanis  2 , Jessica R Trotter  1 , Danielle E Arnold  3 , Jacqueline D Squire  4 , Sharon Kidd  5 , Suhag Parikh  6 , Rebecca A Marsh  7 , Linda M Griffith  8 , Kanwaldeep Mallhi  9 , Deepak Chellapandian  10 , Stephanie Si Lim  11 , Eyal Grunebaum  12 , Kathleen E Sullivan  13 , Peter E Newburger  14 , Mary C Dinauer  15 , Morton J Cowan  5 , Christopher C Dvorak  5 , Elie Haddad  16 , Donald B Kohn  17 , Luigi D Notarangelo  18 , Sung-Yun Pai  3 , Jennifer M Puck  5 , Michael A Pulsipher  19 , Troy R Torgerson  20 , Harry L Malech  18 , Elizabeth M Kang  18 , Felicia B Morton  21 , Jennifer W Leiding  22
Affiliations

High symptom burden in female X-linked chronic granulomatous disease carriers

Mary Ann Miranda et al. Clin Immunol. 2024 Nov.
No abstract available

Keywords: CGD; Heterozygote; XL-CGD.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Overall Clinical Manifestations. Number of respondents with each organ system assessed in the survey. Percentages reflect the number of respondents who reported each organ manifestation over the total number of respondents for each category.
Fig. 2.
Fig. 2.
Self-reported Symptoms with Organ Systems Affected. A. Dermatologic Manifestations; B. Gastrointestinal Manifestations; C. Genitourinary / Fertility Manifestations; D. Hematologic Manifestations; E. Lymphatic / Bleeding Manifestations; F. Pulmonary Manifestations; G. Ophthalmic Manifestations; H. Musculoskeletal / Neurologic Manifestations; I. Rheumatic Manifestations; J. Psychiatric Manifestations; K. Number of Organ Systems Affected. For A-J, n = the number of respondents who completed responses for individual questions. Percentages reflect the number of respondents who reported each symptom over the total number of respondents for each category.
See this image and copyright information in PMC

References

    1. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM, Genetic, biochemical, and clinical features of chronic granulomatous disease, Medicine (Baltimore) 79 (3) (2000) 170–200, 10.1097/00005792-200005000-00004. - DOI - PubMed
    1. Marciano BE, Spalding C, Fitzgerald A, et al., Common severe infections in chronic granulomatous disease, Clin. Infect. Dis. 60 (8) (2015) 1176–1183, 10.1093/cid/ciu1154. - DOI - PMC - PubMed
    1. Henrickson SE, Jongco AM, Thomsen KF, Garabedian EK, Thomsen IP, Noninfectious manifestations and complications of chronic granulomatous disease, J. Pediatr. Infect. Dis. Soc. 7 (Suppl_1) (2018) S18–S24, 10.1093/jpids/piy014. - DOI - PMC - PubMed
    1. Yang AH, Sullivan B, Zerbe CS, et al., Gastrointestinal and hepatic manifestations of chronic granulomatous disease, J Allergy Clin Immunol Pract 11 (5) (2023) 1401–1416, 10.1016/j.jaip.2022.12.039. - DOI - PubMed
    1. Cale CM, Morton L, Goldblatt D, Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology, Clin. Exp. Immunol. 148 (1) (2007) 79–84, 10.1111/J.1365-2249.2007.03321.X. - DOI - PMC - PubMed

LinkOut - more resources